On Monday November 18, 2013, the U.S. Senate passed a bill, by voice-vote, which had earlier cleared the House, moving the legislation on to President Obama’s desk. H.B. 3204 the Drug Quality and Security Act (“DQSA”) passed with bipartisan support, a rare occurrence of late. The DQSA creates a national system which will track the...
United States Joins Whistleblower Lawsuit Against Novartis Pharmaceuticals Philadelphia, Pa, April 26, 2013 PRWeb, Young Law Group (usawhistle.wpenginepowered.com; e-mail: eyoung@young-lawgroup.com) The United States Department of Justice has announced that it is intervening in a qui tam whistleblower suit under the False Claims Act accusing Novartis Pharmaceuticals Corporation of fraudulently billing Medicare, Medicaid, TRICARE, and other federal and state-funded...
U.S. Sen. Grassley: Focuses on update to Whistleblower Protection Act Senator Chuck Grassley of Iowa, a longtime advocate for strong Whistleblower Protections, recently co-sponsored legislation to provide an update to the Whistleblower Protection Act of 1989 by restoring congressional intent of the original law. Grassley said that whistleblowers are being denied protections they should have...




